Management of Periprosthetic Reverse Shoulder Arthroplasty Infections

  • Nicola Ivaldo
  • Tony ManganoEmail author
  • Giovanni Caione
  • Mario Rossoni
  • Giovanni Riccio


Since the time of the reported first shoulder arthroplasty, implanted in 1894 and explanted 2 years later by Jean Péan, periprosthetic shoulder infection (PSI) represents a known severe complication of this kind of surgery, with significant clinical and socioeconomic consequences. Published data report infection rates ranging from 1 to 15%, with higher rates after revision surgery than after a primary procedure and higher rates after reverse shoulder arthroplasty than after hemiarthroplasty or total shoulder arthroplasty. The hypothesized reasons for this are multifactorial, encompassing the large dead space caused by the reverse configuration of the joint and the fact the arthroplasty is not surrounded and covered by living tissue in the absence of musculotendinous rotator cuff tissue. However, such hypotheses are mostly based on data coming from or involving the older series of patients treated with RSA, and this could bias a realistic estimation of the problem, just considering TSA and RSA were used to manage relatively different pathologic conditions until recent times.


Periprosthetic reverse shoulder arthroplasty infections Shoulder infections Shoulder prosthesis complications Shoulder spacer Glenohumeral joint infections 


  1. 1.
    Péan J. Des moyens prosthétiques destinis a obtenir la reparation des parties osseuses. Gaz des Hop Paris. 1894;67:291.Google Scholar
  2. 2.
    Péan J. De la prothèse osseuse. Gaz des Hop Paris. 1897;70:594.Google Scholar
  3. 3.
    Schairer WW, Nwachukwu BU, Lyman S, Craig EV, Gulotta LV. National utilization of reverse total shoulder arthroplasty in the United States. J Shoulder Elb Surg. 2015;24:91–7.CrossRefGoogle Scholar
  4. 4.
    Padegimas EM, Maltenfort M, Ramsey ML, Williams GR, Parvizi J, Namdari S. Periprosthetic shoulder infection in the United States: incidence and economic burden. J Shoulder Elb Surg. 2015;24:741–6.CrossRefGoogle Scholar
  5. 5.
    Coste JS, Reig S, Trojani C, Berg M, Walch G, Boileau P. The management of infection in arthroplasty of the shoulder. J Bone Joint Surg Br. 2004;86(1):65–9.CrossRefGoogle Scholar
  6. 6.
    Sperling JW, Kozak TK, Hanssen AD, Cofield RH. Infection after shoulder arthroplasty. Clin Orthop Relat Res. 2001;382:206–16.CrossRefGoogle Scholar
  7. 7.
    Trappey GJ, O’Connor DP, Edwards TB. What are the instability and infection rates after reverse shoulder arthroplasty? Clin Orthop Relat Res. 2011;469(9):2505–11.CrossRefGoogle Scholar
  8. 8.
    Richards J, Inacio MC, Beckett M, Navarro RA, Singh A, Dillon MT, Sodl JF, Yian EH. Patient and procedure-specific risk factors for deep infection after primary shoulder arthroplasty. Clin Orthop Relat Res. 2014;472:2809–15.CrossRefGoogle Scholar
  9. 9.
    Farshad M, Gerber C. Reverse total shoulder arthroplasty - from the most to the least common complication. Int Orthop. 2010;34:1075–82.CrossRefGoogle Scholar
  10. 10.
    Werthel JD, Hatta T, Schoch B, Cofield R, Sperling JW, Elhassan BT. Is previous nonarthroplasty surgery a risk factor for periprosthetic infection in primary shoulder arthroplasty? J Shoulder Elb Surg. 2017;26(4):635–40.CrossRefGoogle Scholar
  11. 11.
    Florschütz AV, Lane PD, Crosby LA. Infection after primary anatomic versus primary reverse total shoulder arthroplasty. J Shoulder Elb Surg. 2015;24(8):1296–301.CrossRefGoogle Scholar
  12. 12.
    Parvizi J, Zmistowski B, Berbari EF, Bauer TW, Springer BD, Della Valle CJ, Garvin KL, Mont MA, Wongworawat MD, Zalavras CG. New definition for periprosthetic joint infection: from the Workgroup of the Musculoskeletal Infection Society. Clin Orthop Relat Res. 2011;469:2992–4.CrossRefGoogle Scholar
  13. 13.
    Parvizi J, Gehrke T. Definition of Periprosthetic Joint Infection. J Arthroplast. 2014;29:1331.CrossRefGoogle Scholar
  14. 14.
    Trampuz A, Widmer AF. Infections associated with orthopaedic implants. Curr Opin Infect Dis. 2006;19:349–56.CrossRefGoogle Scholar
  15. 15.
    Saltzman MD, Marecek GS, Edwards SL, Kalainov DM. Infection after shoulder surgery. J Am Acad Orthop Surg. 2011;19:208–18.CrossRefGoogle Scholar
  16. 16.
    Hudek R, Sommer F, Kerwat M, Abdelkawi AF, Loos F, Gohlke F. Propionibacterium acnes in shoulder surgery: true infection, contamination, or commensal of the deep tissue? J Shoulder Elb Surg. 2014;23:1763–71.CrossRefGoogle Scholar
  17. 17.
    Osmon DR, Berbari EF, Berendt AR, Lew D, Zimmerli W, Steckelberg JM, Rao N, Hanssen A, Wilson WR, Infectious Diseases Society ofAmerica. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2013;56(1):e1–e25.CrossRefGoogle Scholar
  18. 18.
    Zhang AL, Feeley BT, Schwartz BS, Chung TT, Ma CB. Management of deep postoperative shoulder infections: is there a role for open biopsy during staged treatment? J Shoulder Elb Surg. 2015;24:e15–20.CrossRefGoogle Scholar
  19. 19.
    Frangiamore SJ, Saleh A, Grosso MJ, Alolabi B, Bauer TW, Iannotti JP, Ricchetti ET. Early versus late culture growth of Propionibacterium acnes in revision shoulder arthroplasty. J Bone Joint Surg Am. 2015;97:1149–58.CrossRefGoogle Scholar
  20. 20.
    Shahi A, Parvizi J. The role of biomarkers in the diagnosis of periprosthetic joint infection. EFORT Open Rev. 2017;1(7):275–8.CrossRefGoogle Scholar
  21. 21.
    Deirmengian C, Kardos K, Kilmartin P, Cameron A, Schiller K, Parvizi J. Combined measurement of synovial fluid α-Defensin and C-reactive protein levels: highly accurate for diagnosing periprosthetic joint infection. J Bone Joint Surg Am. 2014;96:1439–45.CrossRefGoogle Scholar
  22. 22.
    Bauer T, Parvizi J, Kobayashi KV. Diagnosis of periprosthetic infection. J Bone Joint Surg Am. 2006;88:869–82.PubMedGoogle Scholar
  23. 23.
    Gemmel F, Van den Wyngaert H, Love C, Welling MM, Gemmel P, Palestro CJ. Prosthetic joint infections: radionuclide state-of-the-art imaging. Eur J Nucl Med Mol Imaging. 2012;39(5):892–909.CrossRefGoogle Scholar
  24. 24.
    Romanò CL, Borens O, Monti L, Meani E, Stuyck J. What treatment for periprosthetic shoulder infection? Results from a multicentre retrospective series. Int Orthop. 2012;36:1011–7.CrossRefGoogle Scholar
  25. 25.
    Zavala JA, Clark JC, Kissenberth MJ, Tolan SJ, Hawkins RJ. Management of deep infection after reverse total shoulder arthroplasty: a case series. J Shoulder Elb Surg. 2012;21(10):1310–5.CrossRefGoogle Scholar
  26. 26.
    Klatte TO, Junghans K, Al-Khateeb H, Rueger JM, Gehrke T, Kendoff D, Neumann J. Single-stage revision for periprosthetic shoulder infection: outcomes and results. Bone Joint J. 2013;95-B:391–5.CrossRefGoogle Scholar
  27. 27.
    Beekman PD, Katusic D, Berghs BM, Karelse A, De Wilde L. One-stage revision for patients with a chronically infected reverse total shoulder replacement. J Bone Joint Surg Br. 2010;92-B:817–22.CrossRefGoogle Scholar
  28. 28.
    George DA, Volpin A, Scarponi S, Haddad FS, Romanò CL. Does exchange arthroplasty of an infected shoulder prosthesis provide better eradication rate and better functional outcome, compared to a permanent spacer or resection arthroplasty? a systematic review. BMC Musculoskelet Disord. 2016;17(1):52–60.CrossRefGoogle Scholar
  29. 29.
    Bonnevialle N, Dauzères F, Toulemonde J, Elia F, Laffosse JM, Mansat P. Periprosthetic shoulder infection: an overview. EFORT Open Rev. 2017;2(4):104–9.CrossRefGoogle Scholar
  30. 30.
    Cuff DJ, Virani NA, Levy J, Frankle MA, Derasari A, Hines B, Pupello DR, Cancio M, Mighell M. The treatment of deep shoulder infection and glenohumeral instability with debridement, reverse shoulder arthroplasty and postoperative antibiotics. J Bone Joint Surg Br. 2008;90:336–42.CrossRefGoogle Scholar
  31. 31.
    Strickland JP, Sperling JW, Cofield RH. The results of two-stage re-implantation for infected shoulder replacement. J Bone Joint Surg Br. 2008;90:460–5.CrossRefGoogle Scholar
  32. 32.
    Assenmacher AT, Alentorn-Geli E, Dennison T, Baghdadi YMK, Cofield RH, Sánchez-Sotelo J, Sperling JW. Two-stage reimplantation for the treatment of deep infection after shoulder arthroplasty. J Shoulder Elb Surg. 2017;26(11):1978–83.CrossRefGoogle Scholar
  33. 33.
    Farshad M, Grögli M, Catanzaro S, Gerber C. Revision of reversed total shoulder arthroplasty. Indications and outcome. BMC Musculoskelet Disord. 2012;13:160–5.CrossRefGoogle Scholar
  34. 34.
    Sabesan VJ, Ho JC, Kovacevic D, Iannotti JP. Two-stage reimplantation for treating prosthetic shoulder infections. Clin Orthop Relat Res. 2011;469(9):2538–43.CrossRefGoogle Scholar
  35. 35.
    Anagnostakos K, Wilmes P, Schmitt E, Kelm J. Elution of gentamicin and vancomycin from polymethyl methacrylate beads and hip spacers in vivo. Acta Orthop. 2009;80:193–7.CrossRefGoogle Scholar
  36. 36.
    Verhelst L, Stuyck J, Bellemans J, Debeer P. Resection arthroplasty of the shoulder as a salvage procedure for deep shoulder infection: does the use of a cement spacer improve outcome? J Shoulder Elb Surg. 2011;20:1224–33.CrossRefGoogle Scholar
  37. 37.
    Ivaldo N, Mangano T, Caione G, Rossoni M, Ligas A. Customized tantalum-augmented reverse shoulder arthroplasty for glenoid bone defect and excessive medialization: description of the technique. Musculoskelet Surg. 2016;100(Suppl 1):13–8.CrossRefGoogle Scholar
  38. 38.
    Rispoli DM, Sperling JW, Athwal GS, Schleck CD, Cofield RH. Pain relief and functional results after resection arthroplasty of the shoulder. J Bone Joint Surg Br. 2007;89-B:1184–7.CrossRefGoogle Scholar
  39. 39.
    Saltzman MD, Nuber GW, Gryzlo SM, Marecek GS, Koh JL. Efficacy of surgical preparation solutions in shoulder surgery. J Bone Joint Surg Am. 2009;91-A:1949–53.CrossRefGoogle Scholar
  40. 40.
    Koh CK, Marsh JP, Drinković D, Walker CG, Poon PC. Propionibacterium acnes in primary shoulder arthroplasty: rates of colonization, patient risk factors, and efficacy of perioperative prophylaxis. J Shoulder Elb Surg. 2016;25(5):846–52.CrossRefGoogle Scholar
  41. 41.
    Rezapoor M, Nicholson T, Tabatabaee RM, Chen AF, Maltenfort MG, Parvizi J. Povidone-iodine-based solutions for decolonization of nasal Staphylococcus aureus: a randomized, prospective, placebo-controlled study. J Arthroplast. 2017;32(9):2815–9.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Nicola Ivaldo
    • 1
    • 2
  • Tony Mangano
    • 1
    • 2
    Email author
  • Giovanni Caione
    • 1
    • 2
  • Mario Rossoni
    • 1
    • 2
  • Giovanni Riccio
    • 3
  1. 1.Unit of Shoulder and Elbow SurgeryOspedale Humanitas—San Pio XMilanItaly
  2. 2.Department of Orthopaedic and TraumatologyCasa di Cura Villa IgeaAcqui TermeItaly
  3. 3.Department of Infectious Diseases and Septic Surgery (MIOS)Ospedale S.M. di MisericordiaAlbengaItaly

Personalised recommendations